Cargando…

β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians

Type 2 diabetes (T2DM) is one of the most serious global health problems and is mainly a result of the drastic increase in East Asia, which includes over a fourth of the global diabetes population. Lifestyle factors and ethnicity are two determinants in the etiology of T2DM, and lifestyle changes su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yabe, Daisuke, Seino, Yutaka, Fukushima, Mitsuo, Seino, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2015
Materias:	Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420838/ https://www.ncbi.nlm.nih.gov/pubmed/25944304 http://dx.doi.org/10.1007/s11892-015-0602-9

Ejemplares similares

The Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic Diseases
por: Sethupathy, Praveen
Publicado: (2016)

Health Effects of Fructose and Fructose-Containing Caloric Sweeteners: Where Do We Stand 10 Years After the Initial Whistle Blowings?
por: Tappy, Luc, et al.
Publicado: (2015)

The Janus Head of Oxidative Stress in Metabolic Diseases and During Physical Exercise
por: Pesta, Dominik, et al.
Publicado: (2017)

Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbidities
por: Ciba, Iris, et al.
Publicado: (2020)

Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth‐onset type 2 diabetes
por: Reid, Lauren A., et al.
Publicado: (2022)

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes
por: Barrientos‐Pérez, Margarita, et al.
Publicado: (2022)

Association of three insulin resistance indices with hypertension and body weight among Uyghur adults in rural areas of Xinjiang, China
por: Mao, YiDan, et al.
Publicado: (2022)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

Type 2 Diabetes: Multiple Genes, Multiple Diseases
por: Udler, Miriam S.
Publicado: (2019)

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
por: Ortiz-Martínez, Margarita, et al.
Publicado: (2022)

Rapid progression of type 2 diabetes and related complications in children and young people—A literature review
por: Barrett, Timothy, et al.
Publicado: (2020)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance
por: Mathieu, Chantal, et al.
Publicado: (2017)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
por: Seino, Yutaka, et al.
Publicado: (2016)

Accumulation of childhood adversities and type 1 diabetes risk: a register-based cohort study of all children born in Denmark between 1980 and 2015
por: Bengtsson, Jessica, et al.
Publicado: (2020)

Is There Evidence to Support Use of Premixed or Prandial Insulin Regimens in Insulin-Naive or Previously Insulin-Treated Type 2 Diabetic Patients?
por: Yki-Järvinen, Hannele, et al.
Publicado: (2013)

GIP and GLP‐1, the two incretin hormones: Similarities and differences
por: Seino, Yutaka, et al.
Publicado: (2010)

Early Insulinization to Prevent Diabetes Progression
por: Raz, Itamar, et al.
Publicado: (2013)

Insulin Pump for Type 2 Diabetes: Use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes
por: Reznik, Yves, et al.
Publicado: (2013)

Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs: When and for whom?
por: Mosenzon, Ofri, et al.
Publicado: (2013)

Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?
por: Del Prato, Stefano, et al.
Publicado: (2013)

Combining Incretin-Based Therapies With Insulin: Realizing the potential in type 2 diabetes
por: Vora, Jiten
Publicado: (2013)

Systems Biology Approaches and Applications in Obesity, Diabetes, and Cardiovascular Diseases
por: Meng, Qingying, et al.
Publicado: (2012)

Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications
por: Peters, Sanne A. E., et al.
Publicado: (2015)

Digital Diabetes Management: A Literature Review of Smart Insulin Pens
por: Heinemann, Lutz, et al.
Publicado: (2021)

Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease
por: Houben, A. J., et al.
Publicado: (2011)

Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity
por: Patel, S. A., et al.
Publicado: (2012)

Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary
por: Sparre, Thomas, et al.
Publicado: (2022)

The Asian Association for the Study of Diabetes: The first 10 years and the next 10 years
por: Seino, Yutaka, et al.
Publicado: (2020)

Mechanisms of Beta Cell Dysfunction Associated With Viral Infection
por: Petzold, Antje, et al.
Publicado: (2015)

Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2021)

The Impact of Pancreatic Beta Cell Heterogeneity on Type 1 Diabetes Pathogenesis
por: Benninger, Richard K. P., et al.
Publicado: (2018)

The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis
por: Ramos-Rodríguez, Mireia, et al.
Publicado: (2021)

Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?
por: Yabe, Daisuke, et al.
Publicado: (2017)

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
por: Ly, Trang T., et al.
Publicado: (2018)

Lipidomic Abnormalities During the Pathogenesis of Type 1 Diabetes: a Quantitative Review
por: Suvitaival, Tommi
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knu7mg1o5bg6shmgk1ubmf0kje